These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Physiopathology of scleroderma]. Fleischmajer R; Perlish JS; Maquart FX; Kalis B Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310 [TBL] [Abstract][Full Text] [Related]
10. Lymphocyte markers in patients with progressive systemic sclerosis. Czirják L; Dankó K; Sonkoly I; Bodolay E; Szegedi G Acta Med Hung; 1985; 42(3-4):109-14. PubMed ID: 2937012 [TBL] [Abstract][Full Text] [Related]
11. [Disorders of cellular immunity in systemic scleroderma]. Sierakowski SJ; Kucharz EJ Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641 [No Abstract] [Full Text] [Related]
12. [Pathogenesis of systemic scleroderma: immunological aspects]. Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899 [TBL] [Abstract][Full Text] [Related]
13. [Antibodies to collagen type I and fibronectin in patients with scleroderma systemic ]. Taova MK; Kurdanov KA Klin Med (Mosk); 1996; 74(7):50-1. PubMed ID: 8992117 [TBL] [Abstract][Full Text] [Related]
14. T lymphocyte subpopulations in progressive systemic sclerosis defined by monoclonal antibodies. Czirják L; Surányi P; Dankó K; Szegedi G Acta Med Hung; 1985; 42(3-4):129-32. PubMed ID: 3879347 [TBL] [Abstract][Full Text] [Related]
15. [Anti-collagen IV antibodies in patients with scleroderma and idiopathic Raynaud's phenomenon]. Gabrielli A; Montroni M; Rupoli S; Caniglia ML; Danieli G Recenti Prog Med; 1985 Jan; 76(1):21-2. PubMed ID: 3991970 [No Abstract] [Full Text] [Related]
16. Hypothesis for the pathogenesis of systemic sclerosis. Furst DE; Clements PJ J Rheumatol Suppl; 1997 May; 48():53-7. PubMed ID: 9150119 [TBL] [Abstract][Full Text] [Related]
17. [The state of cellular immunity in patients with systemic scleroderma]. Borisova AM; Stepanova EN; Burnaeva ZN Ter Arkh; 1987; 59(4):46-8. PubMed ID: 3590004 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060 [TBL] [Abstract][Full Text] [Related]
19. Early immune events in scleroderma. Postlethwaite AE Rheum Dis Clin North Am; 1990 Feb; 16(1):125-39. PubMed ID: 2406803 [TBL] [Abstract][Full Text] [Related]
20. Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. McKown KM; Carbone LD; Bustillo J; Seyer JM; Kang AH; Postlethwaite AE Arthritis Rheum; 2000 May; 43(5):1054-61. PubMed ID: 10817559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]